Clinical Trials Directory

Trials / Unknown

UnknownNCT04766047

The Effect of Dexmedetomidine on Kidney Function in EVAR

The Effect of Dexmedetomidine on the Incidence of Acute Kidney Injury in EVAR

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University of Thessaly · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the effect of dexmedetomidine on the incidence of postoperative acute kidney injury in patients undergoing EVAR under general anesthesia

Detailed description

This study will compare the incidence of AKI after elective EVAR conducted under general anesthesia with and without administration of dexmedetomidine. The AKI will be evaluated through measuring NGAL and c-cystatin.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineAdministration of dexmedetomidine intraoperatively

Timeline

Start date
2021-08-30
Primary completion
2023-11-30
Completion
2024-02-01
First posted
2021-02-23
Last updated
2021-04-28

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT04766047. Inclusion in this directory is not an endorsement.

The Effect of Dexmedetomidine on Kidney Function in EVAR (NCT04766047) · Clinical Trials Directory